OTC · IDXG
Interpace Biosciences, Inc.
$5.72+$0.77 (+15.56%)
Interpace Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.33% below the high.
Loading market information…
OTC · RMSL · USD
Stock price, earnings
Quote as of Oct 29, 2026, 06:54 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
REMSleep Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow REMSleep Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:18 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.72+$0.77 (+15.56%)
Interpace Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.33% below the high.
$3.10$0.00 (0.0%)
PD-Rx Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 7.46% below the high.
$0.03$0.00 (0.0%)
Cardiac Biotech Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.00$0.00 (0.0%)
Rennova Health, Inc.: Healthcare · Medical - Diagnostics & Research.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.03$0.00 (0.0%)
Fuse Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.00+$0.00 (+33.33%)
Lifeline Biotechnologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.64% below the high.
$0.00+$0.00 (+11.76%)
Metawells Oil & Gas Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.5% below the high.
